Palladone Extended Release
Capsules (hydromorphone)
FDA approved Palladone (hydromorphone hydrochloride
extended-release) Capsules for the management of persistent,
moderate to severe pain in patients requiring continuous,
around-the-clock opioid analgesia with a high potency opioid for an
extended period of time generally weeks to months or longer.
Back
to Top
Back to Drug Info
Date created: September 24, 2004, updated September 27, 2004 |